%0 Journal Article
%T Teriflunomide induces a tolerogenic bias in blood immune cells of MS patients
%A Amalia Tejeda©\Velarde
%A Enric Monreal
%A Ernesto Rold¨¢n
%A Eulalia Rodr¨ªguez©\Mart¨ªn
%A Jos¨¦ C. ¨¢lvarez©\Cerme£¿o
%A Lucienne Costa©\Frossard
%A Noelia Villarrubia
%A Rafael Arroyo
%A Roberto ¨¢lvarez©\Lafuente
%A Silvia Medina
%A Susana Sainz de la Maza
%J Archive of "Annals of Clinical and Translational Neurology".
%D 2019
%R 10.1002/acn3.711
%X Teriflunomide, a disease©\modifying treatment approved for multiple sclerosis (MS), inhibits reversibly dihydroorotate dehydrogenase, an enzyme involved in de novo pyrimidine biosynthesis and down©\regulates proliferation of activated lymphocytes. We aimed to study the impact of this drug in the lymphocyte profiles of MS patients
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389853/